Life Sciences News

OrthogenRx's GenVisc 850 Approved by the FDA for Treatment of Osteoarthritis Knee Pain

October 8, 2015

OrthogenRx Inc. has announced the US Food and Drug Administration (FDA) approval of GenVisc 850® (sodium hyaluronate) for the treatment of patients with osteoarthritis (OA) knee pain. GenVisc 850® is a solution of purified hyaluronic acid (sodium hyaluronate; HA), similar to the normal knee fluid. HAs replace the fluid in the knee that has degraded […]

Read More

Rise of the Rest Philly: Pitch Finalists Announced

September 23, 2015

Two are Ben Franklin companies. Two are Project Liberty companies. All are innovators. We are stoked! Here’s the full list for the full Pitch Competition on Tuesday, September 29: SmartPlate – A plate that instantly analyzes everything you eat (Ben Franklin, Project Liberty) Life.io – Solution that motivates and rewards users for tracking and improving […]

Read More

Medtech Stakeholders Meeting Recap: Medtech Thriving in Philadelphia Region

September 16, 2015

Last week’s Medtech Stakeholders meeting reaffirmed three things for the Greater Philadelphia area’s medtech and device sector in a big way: 1) innovation is here; 2) we’re hungry for more, and; 3) the industry knows it. The meeting was hosted by Evolve IP on September 9th, with its 60 attendees buzzing amidst a full agenda […]

Read More

BioBots Announces Commercial Launch of $10K Bioprinter

September 10, 2015

The BioBots bioprinter will reach a significant milestone with its commercial launch at this week’s Tissue Engineering International Regenerative Medicine Society’s World Congress. The bioprinter, which is now available for ordering, goes to market at $10,000 and is revolutionary for its compact design and ease of use. It includes an intuitive, open- cartridge system, which […]

Read More

Capnia Acquires Neonatal Pulmonary Resuscitation Solutions From NeoForce Group, Inc.

September 9, 2015

Acquisition Strengthens Capnia’s Presence in Neonatology NeoForce President and Chief Executive Officer to Join Capnia as General Manager of Neonatology. REDWOOD CITY, CA – September 8, 2015 – Capnia, Inc. (NASDAQ: CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, today announced that […]

Read More

BioBots raises $1.25 million

September 2, 2015

The DreamIt Health company that makes 3D printers for living cells turned to equity crowdfunding, among other sources, to close the round. BioBots, the 3D printing company for living cells, recently closed a $1.25 million funding round. The convertible debt round was from a mix of angel investors, equity crowdfunding investors and seed-stage funds, likeDreamIt Ventures […]

Read More

Ben Franklin alum uses 3D printing tech to make drugs, raises $39M

September 1, 2015

A Bucks County specialty pharmaceutical company that is using three-dimensional technology to make drugs that are easier to swallow has raised $38.75 million through a debt sale, according to documents filed with the Securities and Exchange Commission. Aprecia Pharmaceuticals Co. is seeking to raise a total of $52 million, according to the filing. The Langhorne, […]

Read More

A 3D printer that squirts out the building blocks of life

August 24, 2015

As regular listeners (and underwriters) of WHYY’s “The Pulse,” we love when one of our portfolio companies is featured. The BioBots team is getting ready to launch the next version of its 3D tissue printing technology. Listen here to WHYY’s Todd Bookman talk to the team at BioBots.  

Read More

Watch out, Organovo: BioBots launching new line of low-cost 3D bioprinters

August 18, 2015

This September, Philadelphia startup BioBots will roll out a new line of desktop 3D bioprinters — going up against companies like the capital-heavy Organovo. The company’s developing smaller, easier to use, cheaper 3D tissue printing machines. They’ll cost about $10,000, and are geared to let academicians and industry scientists create their own tissues for preclinical research. It […]

Read More

La Salle professor out to ‘change the standard’ of cancer care

August 11, 2015

Name: David Zuzga Title: Co-founder and CEO of BioDetego Other title: Faculty member in the biology department at La Salle University His company: BioDetego was founded three years ago to commercialize cancer diagnostic technology Zuzga developed with his mentor GianMario Pitari while a graduate student at Thomas Jefferson University. Pitari is the company’s other co-founder. […]

Read More

Previous Next